Gut Microbiota Gut Microbiota: Succinct Overview of Impacts on Human Physique and Current Research Status with Future Aspects

Gut Microbiota: Succinct Overview

  • Md. Imran Hossain mr
  • Redwanul Islam Department of Biotechnology and Genetic Engineering, Bangabandhu Sheikh Mujibur Rahman Science and Technology University,Gopalganj-8100, Bangladesh
  • Sanjida Islam Mimi Department of Biotechnology and Genetic Engineering, Bangabandhu Sheikh Mujibur Rahman Science and Technology University,Gopalganj-8100, Bangladesh
  • Zilhas Ahmed Jewel Department of Agriculture, Bangabandhu Sheikh Mujibur Rahman Science and Technology University,Gopalganj-8100, Bangladesh
  • Utsho Ali Haider University Hospital Mannheim Heidelberg University, Germany


A human body is the excellent example of symbiosis in nature. About 10^14 bacteria reside in the human physique as commensal. These microbes make a complex community in entrails is called "gut microbiota". It is estimated that the gut flora is composed more than thousand of different species. These species have various functions in human health and recent research reports on gut microbe’s community those have role in the progress and development of major human disease include cancer, obesity, diabetes, autism, mental depression, hypertension etc. In this review we focused the succinct overview on gut microbe’s origin, behavior, functions, role in major human disease and the current exploration circumstance with next generation perspective.

Keywords: entrails, microbes, microbiota, parasite, immunity, probiotics, diversity, symbiotic, host, dysbiosis.


Download data is not yet available.


Abreu C., Ortiz Lopez A., Gore J. (2018). Pairing off: a bottom-up approach to the human gut microbiome. Mol Syst Biol,14, e8425.
Adams J.B., Johansen L.J., Powell L.D., Quig D., Rubin R.A. (2011). Gastrointestinal flora and gastrointestinal status in children with autism--comparisons to typical children and correlation with autism severity. BMC Gastroenterol, 11, 22 [PMID:21410934 DOI:10.1186/1471-230X-11-22]
Adl S.M., Simpson A.G., Lane C.E., Lukes J., Bass D., Bowser S.S., et al.(2012). The revised classification of eukaryotes. The Journal of Eukaryotic Microbiology, 59(5),429-93. Epub 2012/10/02. doi: 10.1111/j.1550-7408.2012.00644.x. PubMed PMID: 23020233; PubMed Central PMCID: PMC3483872.
Allin, K. H., Tremaroli, V., Caesar, R., Jensen, B. A. H., Damgaard, M. T. F., Bahl, M. I., Licht, T. R., Hansen, T. H., Nielsen, T., Dantoft, T. M., Linneberg, A., Jørgensen, T., Vestergaard, H., Kristiansen, K., Franks, P. W., Hansen, T., Bäckhed, F., Pedersen, O., IMI-DIRECT consortium, & Jørgensen, T. (2018). Aberrant intestinal microbiota in individuals with prediabetes. Diabetologia, 61(4), 810-820.
Bafeta A., Koh M., Riveros C., Ravaud P. (2018). Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review. Ann Intern Med,169, 240e7.
Bambury A., Sandhu K., Cryan J.F., Dinan T.G.(2018) Finding the needle in the haystack: systematic identification of psychobiotics. Br J Pharmacol, 15, 1e9.
Bouvard V., Baan R., Straif K., et al., (2009). A review of human carcinogens—part B: biological agents. Lancet Oncol. 10, 321–322.
Burnett-Hartman A.N., Newcomb P.A., Potter J.D., (2008). Infectious agents and colorectal cancer: a review of Helicobacter pylori, Streptococcus bovis, JC virus, and human papillomavirus. Cancer Epidemiol. Biomarkers Prev. 17, 2970–2979.
Castellarin M., Warren R.L., Freeman J.D., et al., (2011). Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 22, 299.
Cavanna L., Pagani R., Seghini P., et al., (2008). High grade B-cell gastric lymphoma with complete pathologic remission after eradication of Helicobacter pylori infection: report of a case and review of the literature. World J. Surg. Oncol. 6, 35.
Cipriani S., Mencarelli A., Palladino G., Fiorucci S.(2010). Apr. FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats. J. Lipid Res. 51(4), 771–784.
Clarke Gerard, Stilling Roman M., Kennedy Paul J., Stanton Catherine, Cryan John F., Dinan Timothy G. (2014). Minireview: Gut Microbiota: The Neglected Endocrine Organ. Molecular Endocrinology. 28 (8), 122138. doi:10.1210/me.20141108. PMC 5414803. PMID 24892638
de Silva H.J., Millard P.R., Soper N., Kettlewell M., Mortensen N., Jewell D.P.(1991). Effects of the faecal stream and stasis on the ileal pouch mucosa. Gut, 32, 1166-1169 [PMID: 1955172]
De, M., Bhattacharya, M., Saha, A., Basu, I., Ganguli, S., & Dey, S. (2019). Influence of Oral Microbiome on Human Health: an Overview. International Journal of Advancement in Life Sciences Research, 2(1), 16-21. Doi:
Dridi B., Fardeau M.L., Ollivier B., Raoult D., Drancourt M.(2012). Methanomassiliicoccus luminyensis gen. nov., sp. nov., a methanogenic archaeon isolated from human faeces. International Journal of Systematic and Evolutionary Microbiology. 62(Pt 8), 1902-7. Epub 2012/08/04. doi: 10.1099/ijs.0.033712-0. PubMed PMID: 22859731
Dridi B., Henry M., Khechine A. E. l.,Raoult D., Drancourt M. (2009). High prevalence of 616 Methanobrevibacter smithii and Methanosphaera stadtmanae detected in the human gut using 617 an improved DNA detection protocol. PloS one. 2009;4(9):e7063. Epub 2009/09/18. doi:
618 10.1371/journal.pone.0007063. PubMed PMID: 19759898; PubMed Central PMCID:619 PMC2738942. 620
Fallani, M., Young, D., Scott, J., et al., (2010). Intestinal microbiota of 6-week-old infants across Europe: geographic influence beyond delivery mode, breastfeeding, and antibiotics. J. Pediatr. Gastroenterol. Nutr. 51, 77–84.
Fei, N., Zhao, L., 2013. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 7, 880–884.
Finegold S.M., Dowd S.E., Gontcharova V., Liu C., Henley K.E., Wolcott R.D., Youn E., Summanen P.H., Granpeesheh D., Dixon D., Liu M., Molitoris D.R., Green J.A. (2010). Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe, 16, 444-453 [PMID:20603222 DOI: 10.1016/j.anaerobe.2010.06.008]
Finegold S.M., Molitoris D., Song Y., Liu C., Vaisanen M.L., Bolte E., McTeague M., Sandler R., Wexler H., Marlowe E.M., Collins M.D., Lawson P.A., Summanen P., Baysallar M., Tomzynski T.J., Read E., Johnson E., Rolfe R., Nasir P., Shah H., Haake D.A., Manning P., Kaul A.(2002).Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis, 35, S6-S16 [PMID: 12173102 DOI: 10.1086/341914]
Fischbach M.A. Microbiome: focus on causation and mechanism. Cell 2018;174:785e90.
Foca A., Liberto M.C., Quirino A., Marascio N., Zicca .E, Pavia G. (2015). Gut inflammation and immunity: what is the role of the human gut virome? Mediators of inflammation. 326032, Epub 2015/05/07. doi: 10.1155/2015/326032. PubMed PMID: 25944980; PubMed Central PMCID: PMC4405218
Fond G., Boukouaci W., Chevalier G., Regnault A., Eberl G., Hamdani N., Dickerson F., Macgregor A., Boyer L., Dargel A., Oliveira J., Tamouza R., Leboyer M. (2015). The “psychomicrobiotic”: Targeting microbiota in major psychiatric disorders: A systematic review.
Pathol Biol (Paris), 63, 35-42. [PMID: 25468489 DOI:10.1016/j.patbio.2014.10.003]
Geurts L., Neyrinck A.M., Delzenne N.M., Knauf C., Cani P.D. (2015). Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics. Benef Microbes, 1e15.
Gibson Glenn R. (2004). Fibre and effects on probiotics (the prebiotic concept). Clinical Nutrition Supplements. 1 (2), 2531. doi:10.1016/j.clnu.2004.09.005.
Goodwin A.C., Destefano Shields C.E., Wu S., et al., (2011). Polyamine catabolism contributes to enterotoxigenicBacteroides fragilis-induced colon tumorigenesis. Proc. Natl. Acad. Sci. USA 108, 15354–15359.
Grenham S., Clarke G., Cryan J.F., Dinan T.G. (2011). Brain-gut-microbe communication in health and disease. Front Physiol 2011;2:94.
Guo Z., Zhang J., Wang Z., Ang K.Y., Huang S., Hou Q. (2016). Intestinal microbiota distinguish gout patients from healthy humans. Sci Rep, 6:20602e12.
Haba R., Shintani N., Onaka Y., Wang H., Takenaga R., Hayata A., Baba A., Hashimoto H. (2012). Lipopolysaccharide affects exploratorybehaviors toward novel objects by impairing cognition and/ormotivation in mice: Possible role of activation of the centralamygdala. Behav Brain Res, 228, 423-431. [PMID: 22209851DOI: 10.1016/j.bbr.2011.12.027].
Hamad I., Raoult D., Bittar F.(2015). Repertory of Eukaryotes (Eukaryome) in the Human Gastrointestinal Tract: Taxonomy and Detection Methods. Parasite Immunology. Epub 2015/10/06. doi: 10.1111/pim.12284. PubMed PMID: 26434599.
Hanninen A., Toivonen R, P. € oysti, Belzer C., Plovier H.(2017) €Akkermansia muciniphila induces gut microbiota remodeling and controls islet autoimmunity in NOD mice. Gut, 67, 1445e53.
Huang J.Q., Sridhar S., Chen Y., et al., (1998). Meta-analysis of the relationship between Helicobacter pyloriseropositivity and gastric cancer. Gastroenterology 114, 1169–1179.
Hugon P., Dufour J.C., Colson P., Fournier P.E., Sallah K., Raoult D. (2015). A comprehensive 436 repertoire of prokaryotic species identified in human beings. The Lancet Infectious diseases. 437, 15(10),1211-9. doi: 10.1016/S1473-3099(15)00293-5. PubMed PMID: 26311042.
Hugon P., Dufour J.C., Colson P., Fournier P.E., Sallah K., Raoult D. (2015). A comprehensive repertoire of prokaryotic species identified in human beings. The Lancet Infectious diseases. 15(10), 1211-9. doi: 10.1016/S1473-3099(15)00293-5. PubMed PMID: 26311042
Jie Z., Xia H., Zhong S., Feng Q., Li S., Liang S., et al. (2017). The gut microbiome in atherosclerotic cardiovascular disease. Nat Commun, 8,845e57.
Joglekar P., Segre J.A. (2017). Building a translational microbiome toolbox. Cell,169,378e8.
Kang D.W., Park J.G., Ilhan Z.E., Wallstrom G., Labaer J., Adams J.B., Krajmalnik-Brown R. (2013). Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, e68322 [PMID: 23844187 DOI: 10.1371/journal.pone.0068322]
Kashyap P.C., Chia N., Nelson H., Segal E., Elinav E.(2017). Microbiome at the frontier of personalized medicine. Mayo Clin Proc, 92,1855e64.
Kastin A.J., Pan W. (2010). Concepts for biologically active peptides. CurrPharm, 16, 3390-3400 [PMID: 20726835]
Klein E.J., Boster D.R., Stapp J.R., Wells J.G., Qin X., Clausen C.R., et al. (2006). Diarrhea etiology in a Children's Hospital Emergency Department: a prospective cohort study. Clin Infect Dis. 43(7),807-13. doi: 10.1086/507335. PubMed PMID: 16941358.
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., El-Omar, E. M., Brenner, D., Fuchs, C. S., Meyerson, M., & Garrett, W. S. (2013). Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell host & microbe, 14(2), 207–215.
Le CE, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G. (2013). Richness of human gut microbiome correlates with metabolic markers. Nature, 500, 541e6.
Ley R. E., Turnbaugh P.J, Klein S, Gordon J.I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature, 444(7122), 1022-3. doi: 10.1038/4441022a. PubMed PMID: 17183309
Lloyd-Price J., Abu-Ali G., Huttenhower C. (2016). The healthy human microbiome. Genome Med,8,1e11.
Machiels K., Joossens M., Sabino J., et al., (2013). A decrease of the butyrate-producing species Roseburia hominis and Faecali-bacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut 63, 1275–1283.
Mager D.L. (2006). Bacteria and cancer: cause, coincidence or cure? A review. J. Transl. Med. 4, 14.
Malinen E, Krogius-Kurikka L., Lyra A., Nikkila J., Jaaskelainen A., Rinttila T., et al. (2010). Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World Journal of Gastroenterology : WJG. 16(36), 4532-40. PubMed PMID: 20857523; PubMed Central PMCID: PMCPMC2945484
Mantis N. J., Rol N., Corthésy B. (2011). Secretory IgA's complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunology. 4 (6), 603, 11. doi:10.1038/mi.2011.41. PMC 3774538. PMID 21975936
Marchesi J. R., Adams D. H., Fava F., Hermes G. D., Hirschfield G.M., Hold G., et al. (2015). The gut microbiota and host health: a new clinical frontier. Gut. doi: 10.1136/gutjnl-2015-309990. PubMed PMID: 26338727.
Marchesi J.R., Dutilh B.E., Hall N., et al., (2011). Towards the human colorectal cancer microbiome. PLoS One 6,e2044.
Maslowski K.M., Mackay C.R. (2011). Diet, gut microbiota and immune
responses. Nat Immunol, 12, 5–9.
Mata L.J., Carrillo C., Villatoro E.(1969). Fecal microflora in health persons in a preindustrial region. Appl Microbiol. 17(4), 596-602. PubMed PMID: 4890749; PubMed Central PMCID: PMCPMC377749.
Mazmanian S.K., Round J.L., Kasper D.L., (2008). A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453, 620–625.
Miller T.L., Wolin M.J. (1985). Methanosphaera-Stadtmaniae Gen-Nov, Sp-Nov - a Species That Forms Methane by Reducing Methanol with Hydrogen. Arch Microbiol. 141(2), 116-22. doi: Doi 10.1007/Bf00423270. PubMed PMID: WOS:A1985AHM2800003.
Montiel-Castro A.J., Gonzalez-Cervantes R.M., Bravo-Ruiseco G., Pacheco-Lopez G. (2013). The microbiota-gut-brain axis: neurobehavioral correlates, health and sociality. Front Integr Neurosci 7, 70.
Natividad J.M., Verdu E.F. (2013). Modulation of intestinal barrier by intestinal microbiota: pathological and therapeutic implications. Pharmacol Res, 69, 42-51. [PMID: 23089410 DOI: 10.1016/
Newman J.V., Kosaka T., Sheppard B.J., et al., (2001). Bacterial infection promotes colon tumorigenesis inApc(Min/+) mice. J. Infect. Dis. 184, 227–230.
Nottingham P.M., Hungate R.E. (1968). Isolation of methanogenic bacteria from feces of man. 613 Journal of bacteriology. 96(6), 2178-9. Epub 1968/12/01. PubMed PMID: 4881707; 614 PubMed Central PMCID: PMC252579. 615
Parkin D.M.,(2006). The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118, 3030–3044.
Parracho H.M., Bingham M.O., Gibson G.R., Mc Cartney AL. (2005). Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol, 54, 987-991 [PMID: 16157555 DOI: 10.1099/jmm.0.46101-0]
Penders J., Stobberingh E.E., Van den Brandt P.A., et al.(2007). The role of intestinal microbiota in the development of atopic disorders. Allergy, 62,1223–36.
Quigley, E. M (2013). "Gut bacteria in health and disease". Gastroenterology & hepatology. 9 (9): 560 9. PMC 3983973. PMID 24729765
Rajilic-Stojanovic M., de Vos W.M. (2014). The first 1000 cultured species of the human gastrointestinal microbiota. FEMS microbiology reviews. 38(5),996-1047. Epub 2014/05/28. doi: 10.1111/1574-6976.12075. PubMed PMID: 24861948; PubMed Central PMCID: PMC4262072.
Rajilic-Stojanovic, M., Biagi, E., Heilig, H., Kajander, K., Kekkonen, R., Tims, S. et al. (2011). Global and deep molecular analysis of microbiota
signatures in fecal samples from patients with irritable bowel syndrome. Gastroenterology, 141, 1792–1801.
Reinoso Webb Cynthia, Koboziev Iurii, Furr Kathryn L, Grisham Matthew B. (2016). Protective and pro-inflammatory roles of intestinal bacteria. Pathophysiology. 23 (2), 67- 80. doi:10.1016/j.pathophys.2016.02.002. PMC 4867289. PMID 26947707
Round J.L., O’Connell R.M., Mazmanian S.K. (2010). Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun; 34, J220-J225 [PMID: 19963349 DOI:10.1016/j.jaut.2009.11.007]
Scaldaferri F, Pizzoferrato M, Gerardi V, Lopetuso L, Gasbarrini A. (2012). The gut barrier: new acquisitions and therapeutic approaches. J Clin Gastroenterol, 46 Suppl: S12-S17 [PMID: 22955350 DOI:10.1097/MCG.0b013e31826ae849]
Seksik P., Sokol H., Lepage P. et al.(2006). Review article: the role of bacteria in
onset and perpetuation of inflammatory bowel disease. Aliment Pharmacol Ther, 24(Suppl. 3), 11–8.
Shen Sj., Wong, Connie H.Y. (2016). "Bugging inflammation: Role of the gut microbiota". Clinical & Translational Immunology, 5 (4), e72. doi:10.1038/cti.2016.12.
Sherwood Linda, Willey Joanne, Woolverton Christopher (2013). Prescott's Microbiology (9th ed.). New York: McGraw Hill. pp. 713–21. ISBN 9780073402406. OCLC 886600661.
Sokol H., Lepage P., Seksik P., Dore J., Marteau P. (2007). Molecular comparison of dominant microbiota associated with injured versus healthy mucosa in ulcerative colitis. Gut, 56, 152–4.
Sommer Felix, Bäckhed Fredrik (2013). The gut microbiota — masters of host development and physiology. Nature Reviews Microbiology. 11 (4): 22738. doi:10.1038/nrmicro2974. PMID 23435359.
Song Y., Liu C., Finegold S.M. (2004). Real-time PCR quantitation of clostridia in feces of autistic children. Appl Environ Microbiol, 70, 6459-6465 [PMID: 15528506 DOI: 10.1128/AEM.70.11.6459-6465.2004]
Sonnenburg J.L., Backhed F.(2016). Diet-microbiota interactions as €moderators of human metabolism. Nature, 535, 56e64.
Sullivan A., Edlund C., Nord C.E. (2001). Effect of antimicrobial agents on the ecological 433 balance of human microflora. The Lancet Infectious diseases.1(2), 101-14. Epub 434 2002/03/02. doi: 10.1016/S1473-3099(01)00066-4. PubMed PMID: 11871461.
Sun J., Mustafi R., Cerda S., et al., (2008). Lithocholic acid down-regulation of NF-kappa B activity through vitamin D receptor in colonic cancer cells. J. Steroid Biochem. Mol. Biol. 111, 37–40.
Thomas L.A., Veysey M.J., Bathgate T., et al., (2000). Mechanism for the transit-induced increase in colonicdeoxycholic acid formation in cholesterol cholelithiasis. Gastroenterology 119, 806–815.
Ubraniak C., Gloor G.B., Brackstone M., et al., (2016). The microbiota of breast tissue and its association withtumours. Appl. Environ. Micro. 82, 5039–5048.
University of Glasgow. (2005). The normal gut flora. Available through web archive. Accessed May 22, 2008
Venturelli O.S., Carr A.C., Fisher G., Hsu R.H., Lau R., Bowen B.P., et al. (2018). Deciphering microbial interactions in synthetic human gut microbiome communities. Mol Syst Biol,14, e8157.
Vogt N.M., Kerby R.L., Dill-Mc Farland K.A., Harding S.J., Merluzzi A.P, Johnson S.C., Carlsson C.M., Asthana S., Zetterberg H., Blennow K. et al. (2017). Gut microbiome alterations in Alzheimer’s disease. Sci Rep, 7,1-11.
Vogt N.M., Kerby R.L., Dill-Mc Farland K.A., Harding S.J., Merluzzi A.P., Johnson S.C., Carlsson C.M., Asthana S., Zetterberg H., Blennow K. et al.(2017). Gut microbiome alterations in Alzheimer’s disease. Sci Rep, 7,1-11.
Waldecker M., Kautenburger T., Daumann H., et al., (2008). Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon. J. Nutr. Biochem. 19, 587–593.
Wang B., Yao M., Lv L., Ling Z., Li L. (2017). The human microbiota in health and disease. Engineering, 3,71e82.
Wang L., Christophersen C.T., Sorich M.J., Gerber J.P., Angley M.T., Conlon M.A. (2013). Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism, 4, 42. [PMID: 24188502 DOI:10.1186/2040-2392-4-42]
Wang Y., Kasper L.H.(2014). The role of microbiome in central nervous system disorders. Brain Behav Immun, 38, 1-12. DOI: 10.1016/j.bbi.2013.12.015.
Wang Yan, Kasper Lloyd H. (2014). The role of microbiome in central nervous system disorders. Brain, Behavior, and Immunity. 38, 1–12. doi:10.1016/j.bbi.2013.12.015. PMC 4062078. PMID 24370461.
Williams B.L., Hornig M., Parekh T., Lipkin W.I. (2012). Application of novel PCR-based methods for detection, quantitation, and phylogenetic characterization of Sutterella species in intestinal biopsy samples from children with autism and gastrointestinal disturbances. MBio, 3, pii: e00261-11 [PMID: 22233678 DOI: 10.1128/mBio.00261-11]
Woese C.R., Kandler O., Wheelis M.L.(1990). Towards a natural system of organisms: proposal for the domains Archaea, Bacteria, and Eucarya. Proceedings of the National Academy of Sciences of the United States of America. 87(12), 4576-9.
Yang T., Santisteban M., Rodriguez V., Li E., Ahmari N., Carvajal J.M. (2015). Gut dysbiosis is linked to hypertension. Hypertension, 65, 1331e40.
Yang T., Santisteban M., Rodriguez V., Li E., Ahmari N., Carvajal J.M. (2015). Gut dysbiosis is linked to hypertension. Hypertension, 65,1331e40.
Yoon My Young, Lee Keehoon, Yoon Sang Sun (2014). Protective role of gut commensal microbes against intestinal infections. Journal of Microbiology. 52(12), 983–9. doi:10.1007/s12275-014-4655-2. PMID 25467115.
Zheng X, Zhu J, Zhang X, Cheng M, Zhang Z, Cao J. (2018). The modulatory effect of nanocomplexes loaded with EGCG3ʺMe on intestinal microbiota of high fat diet-induced obesity mice model. J Food Biochem, 42,1e8.
Zhou L, Foster JA. Psychobiotics and the gut-brain axis: in the pursuit of happiness. Neuropsychiatr Dis Treat (2015). 11, 715-723. PMID: 25834446 DOI: 10.2147/NDT.S61997
44 Views | 165 Downloads
How to Cite
Hossain, M. I., Islam, R., Mimi, S., Jewel, Z., & Haider, U. (2020). Gut Microbiota Gut Microbiota: Succinct Overview of Impacts on Human Physique and Current Research Status with Future Aspects. International Journal of Advancement in Life Sciences Research, 3(2), 1-10. Retrieved from
Review Articles